Abstract:The Lamarckian genetic algorithm of AutoDock 3.0 has been employed to dock 40 1,5-diarylpyrazole class compounds into the active sites of cyclooxygenase-2 (COX-2) and cyclooxygenase-1 (COX-1). The binding models were demonstrated in the aspects of inhibitor's conformation, subsite interaction, and hydrogen bonding. The data of geometrical parameters and RMSD values compared with the known inhibitor, SC-558 (43), show that these inhibitors interact respectively with COX-2 and COX-1 in a very similar way. The r(2) values of 0.648 for COX-2 and 0.752 for COX-1 indicate that the calculated binding free energies correlate well with the inhibitory activities. The structural and energetic differences in inhibitory potencies of 1,5-diarylpyrazoles were reasonably explored, and the COX-2/COX-1 selectivity was demonstrated by the three-dimensional (3D) interaction models of inhibitors complexing with these two enzymes. Using the binding conformations of 1,5-diarylpyrazoles, consistent and highly predictive 3D quantitative structure-activity relationship (QSAR) models were developed by performing comparative molecular field analyses (CoMFA) and comparative molecular similarity analyses (CoMSIA). The q(2) values are 0.635 and 0.641 for CoMFA and CoMSIA models, respectively. The predictive ability of these models was validated by SC-558 (43) and a set of 10 other compounds that were not included in the training set. Mapping these models back to the topology of the active site of COX-2 leads to a better understanding of vital diarylpyrazole compounds and COX-2 interactions. Structure-based investigations and the final 3D QSAR results provided possible guidelines and accurate activity predictions for novel inhibitor design.

QSAR and Classification Models of a Novel Series of COX-2 Selective Inhibitors: 1, 5-Diarylimidazoles Based on Support Vector Machines

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

QSAR Research of Novel Tetrandrine Derivatives Against Human Hepatocellular Carcinoma.

QSAR Classification-Based Virtual Screening Followed by Molecular Docking Identification of Potential COX-2 Inhibitors in a Natural Product Library

Qsar Studies on the Cox-2 Inhibition by 3,4-Diarylcycloxazolones Based on Medv Descriptor

Development of COX-2 Inhibitor Models Using Machine Learning Methods

QSAR and Classification Study of 1,4-Dihydropyridine Calcium Channel Antagonists Based on Least Squares Support Vector Machines

A QSAR study of 1,2-diarylimidazole cyclooxygenase-2 inhibitors

Comparative Study of Qsar/Qspr Correlations Using Support Vector Machines, Radial Basis Function Neural Networks, and Multiple Linear Regression

Quantitative Structure–Activity Relationship Study on a Series of Novel Ligands Binding to Central Benzodiazepine Receptor by Using the Combination of Heuristic Method and Support Vector Machines

Enhanced Replacement Method‐based Quantitative Structure–Activity Relationship Modeling and Support Vector Machine Classification of 4‐anilino‐3‐quinolinecarbonitriles As Src Kinase Inhibitors

A novel non-linear approach for establishing a QSAR model of a class of 2-Phenyl-3-(pyridin-2-yl) thiazolidin-4-one derivatives

In Silico Prediction of Inhibition Activity of Pyrazine–Pyridine Biheteroaryls As VEGFR‐2 Inhibitors Based on Least Squares Support Vector Machines

Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking

Virtual Screening For Cox-2 Inhibitors With Random Forest Algorithm And Feature Selection

Studies on 3D Quantitative Structure-Activity Relationships-of 2(4-Methanesulfonylphenyl) Pyran-4-ones As Selective COX-2 Inhibitors

Inhibitory Mode of 1,5-Diarylpyrazole Derivatives Against Cyclooxygenase-2 and Cyclooxygenase-1: Molecular Docking and 3d Qsar Analyses

Quantitative Structure-Activity Relationship Study of the Non-Nucleoside Inhibitors of HCV NS5B Polymerase by Machine Learning Methods

3D-QSAR and Molecular Docking Study on Selectivity of Indolocarbazole Series As Cyclin-Dependent Kinase Inhibitors

QSAR Models for 2-Amino-6-arylsulfonylbenzonitriles and Congeners HIV-1 Reverse Transcriptase Inhibitors Based on Linear and Nonlinear Regression Methods.

QSAR Studies on 4-Anilino-3-quinolinecarbonitriles As Src Kinase Inhibitors Using Robust PCA and Both Linear and Nonlinear Models